282 related articles for article (PubMed ID: 9146938)
1. Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways.
Greiff L; Andersson M; Svensson C; Persson CG
Clin Exp Allergy; 1997 Apr; 27(4):438-44. PubMed ID: 9146938
[TBL] [Abstract][Full Text] [Related]
2. Onset of action of a topical antihistamine as assessed by histamine challenge-induced plasma exudation responses.
Korsgren M; Andersson M; Larsson L; Aldén-Raboisson M; Greiff L
Ann Allergy Asthma Immunol; 2006 Feb; 96(2):345-8. PubMed ID: 16498858
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and pharmacokinetic profiles of intranasal and oral cetirizine in a repeated allergen challenge model of allergic rhinitis.
Korsgren M; Andersson M; Borgå O; Larsson L; Aldén-Raboisson M; Malmqvist U; Greiff L
Ann Allergy Asthma Immunol; 2007 Apr; 98(4):316-21. PubMed ID: 17458426
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis.
Corren J; Storms W; Bernstein J; Berger W; Nayak A; Sacks H;
Clin Ther; 2005 May; 27(5):543-53. PubMed ID: 15978303
[TBL] [Abstract][Full Text] [Related]
5. Effects of two weeks of topical budesonide treatment on microvascular exudative responsiveness in healthy human nasal airways.
Greiff L; Andersson M; Svensson C; Akerlund A; Alkner U; Persson CG
Eur Respir J; 1997 Apr; 10(4):841-5. PubMed ID: 9150322
[TBL] [Abstract][Full Text] [Related]
6. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis.
Berger W; Hampel F; Bernstein J; Shah S; Sacks H; Meltzer EO
Ann Allergy Asthma Immunol; 2006 Sep; 97(3):375-81. PubMed ID: 17042145
[TBL] [Abstract][Full Text] [Related]
7. Effects of intranasal azelastine on the response to nasal allergen challenge.
Saengpanich S; Assanasen P; deTineo M; Haney L; Naclerio RM; Baroody FM
Laryngoscope; 2002 Jan; 112(1):47-52. PubMed ID: 11802037
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of intranasally applied dimethindene maleate solution as spray in adult volunteers with symptoms of seasonal allergic rhinitis in the Vienna challenge chamber.
Kyrein HJ; Horak F; Nirnberger G; Rehn D
Arzneimittelforschung; 1996 Aug; 46(8):794-9. PubMed ID: 9125281
[TBL] [Abstract][Full Text] [Related]
9. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis.
Golden S; Teets SJ; Lehman EB; Mauger EA; Chinchilli V; Berlin JM; Kakumanu S; Lucus T; Craig TJ
Ann Allergy Asthma Immunol; 2000 Jul; 85(1):53-7. PubMed ID: 10923605
[TBL] [Abstract][Full Text] [Related]
10. Challenge-induced plasma exudation and mucinous secretion in human airways.
Greiff L; Andersson M; Coman WB; Lindberg H; Marko-Varga G; Wallwork B; Persson CG
Clin Physiol Funct Imaging; 2005 Jul; 25(4):241-5. PubMed ID: 15972027
[TBL] [Abstract][Full Text] [Related]
11. Desloratadine reduces allergen challenge-induced mucinous secretion and plasma exudation in allergic rhinitis.
Greiff L; Persson CG; Andersson M
Ann Allergy Asthma Immunol; 2002 Oct; 89(4):413-8. PubMed ID: 12392387
[TBL] [Abstract][Full Text] [Related]
12. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis.
Pearlman DS; Grossman J; Meltzer EO
Ann Allergy Asthma Immunol; 2003 Sep; 91(3):258-62. PubMed ID: 14533657
[TBL] [Abstract][Full Text] [Related]
13. Histamine and tryptase in nasal lavage fluid after allergen challenge: effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine.
Jacobi HH; Skov PS; Poulsen LK; Malling HJ; Mygind N
J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):768-72. PubMed ID: 10329808
[TBL] [Abstract][Full Text] [Related]
14. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
Pipkorn P; Costantini C; Reynolds C; Wall M; Drake M; Sanico A; Proud D; Togias A
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089
[TBL] [Abstract][Full Text] [Related]
15. Azelastine nasal spray in the management of seasonal allergic rhinitis.
Meltzer EO; Weiler JM; Dockhorn RJ; Widlitz MD; Freitag JJ
Ann Allergy; 1994 Apr; 72(4):354-9. PubMed ID: 7908778
[TBL] [Abstract][Full Text] [Related]
16. Effect of topical levocabastine on nasal response to allergen challenge and nasal hyperreactivity in perennial rhinitis.
de Graaf-in 't Veld T; Garrelds IM; van Toorenenbergen AW; Mulder PG; Gerth van Wijk R; Boegheim JP
Ann Allergy Asthma Immunol; 1995 Sep; 75(3):261-6. PubMed ID: 7552929
[TBL] [Abstract][Full Text] [Related]
17. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
Borum S; Nielsen K; Bisgaard H; Mygind N
Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
[TBL] [Abstract][Full Text] [Related]
18. Effects of benzalkonium chloride on innate immunity physiology of the human nasal mucosa in vivo.
Storaas T; Andersson M; Persson CG; Steinsvåg SK; Marko-Varga G; Greiff L
Laryngoscope; 2000 Sep; 110(9):1543-7. PubMed ID: 10983958
[TBL] [Abstract][Full Text] [Related]
19. Nasal ocular reflexes and eye symptoms in patients with allergic rhinitis.
Baroody FM; Foster KA; Markaryan A; deTineo M; Naclerio RM
Ann Allergy Asthma Immunol; 2008 Mar; 100(3):194-9. PubMed ID: 18426137
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.
Dorow P; Aurich R; Petzold U
Arzneimittelforschung; 1993 Aug; 43(8):909-12. PubMed ID: 8105785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
